TRIAPEX
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.
TRIAPEX
Industry:
Biopharma Pharmaceutical
Founded:
2008-01-01
Status:
Active
Contact:
(025) 5819-6588
Email Addresses:
[email protected]
Similar Organizations
PRESTIGE BIOLOGICS CO LTD
Prestige Biologics is a CDMO that provides development and manufacturing solutions for clinical biopharmaceuticals from idea to production.
Shilpa Medicare
Shilpa Medicare is dedicated to developing, producing and delivering high-quality Active Pharmaceutical Ingredients.
Investors List
Legend Capital
Legend Capital investment in Series C - TriApex
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-07-17 | Xellar Biosystems | TriApex investment in Seed Round - Xellar Biosystems | 100 M CNY |
More informations about "TriApex"
About us-TriApex
TriApex, founded in 2008, is a contract research organization (CRO) providing pharmaceutical R&D services. We are dedicated to providing nonclinical services including pharmacokinetics โฆSee details»
TriApex - Crunchbase Investor Profile & Investments
Sub-Organization of . Tripod Preclinical Research Laboratories . ... Phone Number (025) 5819-6588; TriApex is an innovative CRO dedicated to โฆSee details»
Investor-TriApex
Tel๏ผ+86 (025) 5819-6588. Email๏ผ[email protected]. Address๏ผNo. 9 Xinglong Road, Jiangbei New Area, Nanjing, ChinaSee details»
TriApex Company Profile | Management and Employees List
TriApex Profile and History. Founded in 2008 and headquartered in Nanjing, China, TriApex is an innovative CRO (Contract Research Organization) dedicated to providing disease-oriented โฆSee details»
Empowering R&D in Special Diseases, "Next Generation" CRO โฆ
May 4, 2023 We look forward to TriApex becoming a next-generation CRO service organization with global influence in future development.โ About Legend Capital Founded in 2001, Legend โฆSee details»
TriApex Laboratories - Products, Competitors, Financials, โฆ
TriApex Laboratories is an innovative contract research organization (CRO) focused on providing integrated solutions for drug development in various disease-oriented fields. The company โฆSee details»
Empowering R&D in Special Diseases, โNext Generationโ CRO โฆ
May 4, 2023 TriAPex will continue to strengthen the restructuring of resources, deepen the understanding of disease biology mechanisms and translational medicine, focus on scientific โฆSee details»
News&Insight-TriApex
TriApex Supported Tavotek Biotherapeutics in Approval of IND of Multi-specific Antibody TAVO412 by FDA. Browse more news. Latest Industry News. 2022-11-28. Online Training โฆSee details»
CRO company TriApex completes Series C financing โฆ
May 5, 2023 TriApex has a professional and dedicated team with lofty career pursuits and is committed to providing high-quality service. We look forward to TriApex becoming a next-generation CRO service organization with global โฆSee details»
TriApex - Investments, Portfolio & Company Exits - Crunchbase
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises. ... Which industries has this organization โฆSee details»
TriApex Nanjing-TriApex - tripod-glp.com
TriApex, founded in 2008, is a contract research organization (CRO) providing pharmaceutical R&D services. We are dedicated to providing nonclinical services including pharmacokinetics โฆSee details»
The Globe and Mail - The Globe and Mail
HONG KONG, May 4, 2023 - (ACN Newswire) - TriApex Laboratories Co., Ltd (hereinafter referred to as "TriApex") recently announced the completion of its Series C financing round, โฆSee details»
Credibility Qualification-TriApex
Witness the development of industry innovation, share TriApex exclusive insights. About us. About us. TriApex Profile Credibility Qualification Social Responsibility Join us. ้ผๆณฐๆฟๆฏ. โฆSee details»
Q&A-TriApex
Q: What is TriApex's business and industrial layout? A: At present, we have set up subsidiaries in Nanjing, Shanghai, Kunming, Hainan and Chengdu, which design Nanjing: non-clinical GLP โฆSee details»
TriApex - Funding, Financials, Valuation & Investors - Crunchbase
May 4, 2023 TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises. ... How much funding has this โฆSee details»
Empowering R&D in Special Diseases, "Next Generation" CRO
HONG KONG, May 4, 2023 - (ACN Newswire) - TriApex Laboratories Co., Ltd (hereinafter referred to as "TriApex") recently announced the completion of its Series C financing round, โฆSee details»
TriApex - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 1, 2024 TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises. Search Crunchbase Start Free โฆSee details»
Three-dimensional genome organization via triplex-forming RNAs
Nov 10, 2021 An increasing number of long noncoding RNAs (lncRNAs) have been proposed to act as nuclear organization factors during interphase. Direct RNA-DNA interactions can be โฆSee details»
Join us-TriApex
TriApex offers broad career development platform, well-defined career development plan and diversified talent development programs to enable your fast growth. Employee wellbeing Have โฆSee details»